Cargando…

Vaccine and Drug Ontology Studies (VDOS 2014)

The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal diseases. Work in both (drugs and vaccines) areas is closely related - fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Cui, He, Yongqun, Arabandi, Sivaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766598/
https://www.ncbi.nlm.nih.gov/pubmed/26918107
http://dx.doi.org/10.1186/s13326-015-0039-8
_version_ 1782417692300410880
author Tao, Cui
He, Yongqun
Arabandi, Sivaram
author_facet Tao, Cui
He, Yongqun
Arabandi, Sivaram
author_sort Tao, Cui
collection PubMed
description The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal diseases. Work in both (drugs and vaccines) areas is closely related - from preclinical research and development to manufacturing, clinical trials, government approval and regulation, and post-licensure usage surveillance and monitoring. Over the last decade, tremendous efforts have been made in the biomedical ontology community to ontologically represent various areas associated with vaccines and drugs – extending existing clinical terminology systems such as SNOMED, RxNorm, NDF-RT, and MedDRA, developing new models such as the Vaccine Ontology (VO) and Ontology of Adverse Events (OAE), vernacular medical terminologies such as the Consumer Health Vocabulary (CHV). The VDOS workshop series provides a platform for discussing innovative solutions as well as the challenges in the development and applications of biomedical ontologies for representing and analyzing drugs and vaccines, their administration, host immune responses, adverse events, and other related topics. The five full-length papers included in this 2014 thematic issue focus on two main themes: (i) General vaccine/drug-related ontology development and exploration, and (ii) Interaction and network-related ontology studies.
format Online
Article
Text
id pubmed-4766598
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47665982016-02-26 Vaccine and Drug Ontology Studies (VDOS 2014) Tao, Cui He, Yongqun Arabandi, Sivaram J Biomed Semantics Editorial The “Vaccine and Drug Ontology Studies” (VDOS) international workshop series focuses on vaccine- and drug-related ontology modeling and applications. Drugs and vaccines have been critical to prevent and treat human and animal diseases. Work in both (drugs and vaccines) areas is closely related - from preclinical research and development to manufacturing, clinical trials, government approval and regulation, and post-licensure usage surveillance and monitoring. Over the last decade, tremendous efforts have been made in the biomedical ontology community to ontologically represent various areas associated with vaccines and drugs – extending existing clinical terminology systems such as SNOMED, RxNorm, NDF-RT, and MedDRA, developing new models such as the Vaccine Ontology (VO) and Ontology of Adverse Events (OAE), vernacular medical terminologies such as the Consumer Health Vocabulary (CHV). The VDOS workshop series provides a platform for discussing innovative solutions as well as the challenges in the development and applications of biomedical ontologies for representing and analyzing drugs and vaccines, their administration, host immune responses, adverse events, and other related topics. The five full-length papers included in this 2014 thematic issue focus on two main themes: (i) General vaccine/drug-related ontology development and exploration, and (ii) Interaction and network-related ontology studies. BioMed Central 2016-02-25 /pmc/articles/PMC4766598/ /pubmed/26918107 http://dx.doi.org/10.1186/s13326-015-0039-8 Text en © Tao et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Editorial
Tao, Cui
He, Yongqun
Arabandi, Sivaram
Vaccine and Drug Ontology Studies (VDOS 2014)
title Vaccine and Drug Ontology Studies (VDOS 2014)
title_full Vaccine and Drug Ontology Studies (VDOS 2014)
title_fullStr Vaccine and Drug Ontology Studies (VDOS 2014)
title_full_unstemmed Vaccine and Drug Ontology Studies (VDOS 2014)
title_short Vaccine and Drug Ontology Studies (VDOS 2014)
title_sort vaccine and drug ontology studies (vdos 2014)
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766598/
https://www.ncbi.nlm.nih.gov/pubmed/26918107
http://dx.doi.org/10.1186/s13326-015-0039-8
work_keys_str_mv AT taocui vaccineanddrugontologystudiesvdos2014
AT heyongqun vaccineanddrugontologystudiesvdos2014
AT arabandisivaram vaccineanddrugontologystudiesvdos2014